Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
bullish
JD Health International
Watchlist
Quiddity Leaderboard for Hang Seng Index Mar 23: Healthcare Names Could Dominate
Index Rebalance
549 Views
05 Feb 2023 03:25
JD Health, BeiGene, WuXi AppTec, Genscript Biotech, and Shandong Weigao Group Medical Polymer are our top picks from the Healthcare Sector for Hang Seng Index addition in March 2023.
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 6-minute read)
Related Insights
More »
JD Health (6618.HK) 23Q3 - Performance Decline Is Inevitable, but There Is Upside Room for Valuation
[JD Health (6618 HK, BUY, TP HK$52) TP Change]: A COVID Hiccup but Environment Is Turning Positive
JD Health (6618.HK) 23H1 - The Beautiful Story Is Over; It's Time to Face Reality
[JD Health (6618 HK, BUY, TP HK$65) TP Change]: Benefit of Alternative Channel Starts to Show
JD Health 1H2023: Reports Operating Profits; Margin Upside Is Very Limited
Trending Collections
More »
India
Equity Bottom-Up
Japan
Sell / Short Ideas
Index Rebalance
Philippines
Event-Driven
Asia Event-Driven
Asia ECM
China
Trending Insights
More »
7&I (3382 JP) - Alimentation Couche-Tard Walks, Lobbing a Letter Bomb
Supreme Court's Final Ruling on Samsung's Lee Jae-Yong on 17 July: Impact on Samsung Group Companies
Krungthai Card (KTC TB): Buy With Both Hands As Pledged Shares Rollover
TSMC 2Q25: A Number of Very Positive Messages, Plus a Major Contradiction on 4Q25 Revenue
PointsBet (PBH AU): Betr Firms "Superior Offer". Expect The Board To Reject. Again
Top Unpaywalled Insights
More »
Veon's (Nasdaq: VEON) Subsidiary Kyivstar Eyes Nasdaq Listing
Reimagining Venture Capital Through Impact Investing | Chris Maher on Disability Innovation
[IO Technicals 2025/28] Bullish Momentum Intensifies
Mid-Year Themes Review - Part II
De-Dollarisation Debate : Unmasking USD Over-Valuation
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
Quiddity Leaderboard for Hang Seng Index Jun 23: Beigene Looks Interesting
05 Apr 2023
[JD Health (6618 HK) Target Price Change]: Strong Execution but Industry Glass Ceiling Remains
24 Mar 2023
HSI Mar23 Index Review/Flows - No Changes But Flows; 100 Names a Loooong Way Off
26 Feb 2023
Quiddity Leaderboard for Hang Seng Index Mar 23: Healthcare Names Could Dominate
05 Feb 2023
Quiddity Primer: The Ongoing Evolution of the Hang Seng Index
02 Feb 2023
Quiddity Flow Expectations HSCEI Mar 23: One Change + Caps for Meituan, Alibaba, and Tencent
29 Jan 2023
Quiddity Primer for HSTECH Rebalance Events
19 Jan 2023
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.54.8
x